Health tech firm Cadence has announced its participation in the Center for Medicare and Medicaid Innovation’s (CMMI) new ACCESS model, a high-stakes experiment in how the U.S. government funds chronic disease management. This program marks a significant departure from the traditional fee-for-service approach, which pays for individual medical tasks regardless of the patient's recovery progress. Instead, the ACCESS model implements a value-based system that rewards specific, measurable health improvements.

Participating providers will manage chronic conditions for a set fee, but they only receive the full reimbursement if their patients hit designated health targets. However, the initial enthusiasm for the program has been tempered by the reveal of lower-than-expected payment rates. While traditional remote monitoring can generate roughly $100 per month per patient, the ACCESS model offers a maximum of only $420 for an entire year.

To navigate these razor-thin margins, industry experts suggest that organizations must lean heavily on artificial intelligence. By automating routine data collection and patient triage, AI can manage the intensive labor that usually requires a fleet of expensive human clinicians. This shift highlights a growing trend where advanced computation is no longer just a luxury tool for diagnostic enhancement, but a structural necessity for the economic survival of modern healthcare delivery.

Health tech firm Cadence has announced its participation in the Center for Medicare and Medicaid Innovation’s (CMMI) new ACCESS model, a high-stakes experiment in how the U.S. government funds chronic disease management. This program marks a significant departure from the traditional fee-for-service approach, which pays for individual medical tasks regardless of the patient's recovery progress. Instead, the ACCESS model implements a value-based system that rewards specific, measurable health improvements.

Participating providers will manage chronic conditions for a set fee, but they only receive the full reimbursement if their patients hit designated health targets. However, the initial enthusiasm for the program has been tempered by the reveal of lower-than-expected payment rates. While traditional remote monitoring can generate roughly $100 per month per patient, the ACCESS model offers a maximum of only $420 for an entire year.

To navigate these razor-thin margins, industry experts suggest that organizations must lean heavily on artificial intelligence. By automating routine data collection and patient triage, AI can manage the intensive labor that usually requires a fleet of expensive human clinicians. This shift highlights a growing trend where advanced computation is no longer just a luxury tool for diagnostic enhancement, but a structural necessity for the economic survival of modern healthcare delivery.